Long-term outcome and prognostic factors in patients with cervical carcinoma: A retrospective study

International Journal of Gynecological Cancer

Volumn 17, Issue 4, 2007, Pages 833-842

  Atahan, I L ^a   Onal, C ^a   Ozyar, E ^a   Yiliz, F ^a   Selek, U ^a   Kose, F ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b SSK Ankara Maternity Hospital   (Turkey)

Author keywords

Brachytherapy; Cervical cancer; Chemoradiotherapy; Prognostic factors; Radiotherapy

Indexed keywords

CISPLATIN; HYDROXYUREA;

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; ENDOMETRIUM CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; UNIVARIATE ANALYSIS; UTERINE CERVIX CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 34447327846     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.00895.x     Document Type: Article

References (53)

1. Moore DH. Cervical cancer. Obstet Gynecol 2006 107: 1152 61.
2. Morris M, Eifel PJ, Lu J et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999 340: 1137 43.
3. Keys HM, Bundy BN, Stehman FB et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999 340: 1154 61.
4. Peters WA 3rd., Liu PY, Barrett RJ 2nd. et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000 18: 1606 13.
5. Rose PG, Bundy BN, Watkins EB et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999 340: 1144 53.
6. Whitney CW, Sause W, Bundy BN et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999 17: 1339 48.
7. Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997 350: 535 40.
8. Petereit DG, Fowler JF, Kinsella TJ. Optimizing the dose rate and technique in cervical carcinoma - balancing cases versus complications. Int J Radiat Oncol Biol Phys 1994 29: 1195 7.
9. Stitt JA, Fowler JF, Thomadsen BR, Buchler DA, Paliwal BP, Kinsella TJ. High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: I. Clinical and radiobiological considerations. Int J Radiat Oncol Biol Phys 1992 24: 335 48.
10. Thomadsen BR, Shahabi S, Stitt JA et al. High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: II. Procedural and physical considerations. Int J Radiat Oncol Biol Phys 1992 24: 349 57.
11. Petereit DG, Pearcey R. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule? Int J Radiat Oncol Biol Phys 1999 43: 359 66.
12. Kaplan E, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958 53: 457 81.
13. Cox D. Regression models and life-tables. J R Stat Soc Ser B 1972 34: 187 220.
14. Lanciano RM, Martz K, Coia LR, Hanks GE. Tumor and treatment factors improving outcome in stage III-B cervix cancer. Int J Radiat Oncol Biol Phys 1991 20: 95 100.
15. Horiot JC, Pigneux J, Pourquier H et al. Radiotherapy alone in carcinoma of the intact uterine cervix according to G.H. Fletcher guidelines: a French cooperative study of 1383 cases. Int J Radiat Oncol Biol Phys 1988 14: 605 11.
16. Lowrey GC, Mendenhall WM, Million RR. Stage IB or IIA-B carcinoma of the intact uterine cervix treated with irradiation: a multivariate analysis. Int J Radiat Oncol Biol Phys 1992 24: 205 10.
17. Coia L, Won M, Lanciano R, Marcial VA, Martz K, Hanks G. The Patterns of Care Outcome Study for cancer of the uterine cervix. Results of the Second National Practice Survey. Cancer 1990 66: 2451 6.
18. Kovalic JJ, Perez CA, Grigsby PW, Lockett MA. The effect of volume of disease in patients with carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1991 21: 905 10.
19. Lanciano RM, Won M, Coia LR, Hanks GE. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys 1991 20: 667 76.
20. Montana GS, Fowler WC, Varia MA, Walton LA, Mack Y, Shemanski L. Carcinoma of the cervix, stage III. Results of radiation therapy. Cancer 1986 57: 148 54.
21. Alvarez RD, Potter ME, Soong SJ et al. Rationale for using pathologic tumor dimensions and nodal status to subclassify surgically treated stage IB cervical cancer patients. Gynecol Oncol 1991 43: 108 12.
22. Averette HE, Nguyen HN, Donato DM et al. Radical hysterectomy for invasive cervical cancer. A 25-year prospective experience with the Miami technique. Cancer 1993 71 (Suppl. 4 1422 37.
23. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1990 38: 352 7.
24. Komaki R, Brickner TJ, Hanlon AL, Owen JB, Hanks GE. Irradiation of para-aortic lymph node metastases from carcinoma of the cervix or endometrium. Preliminary results. Radiology 1983 147: 245 8.
25. Berman ML, Keys H, Creasman W, DiSaia P, Bundy B, Blessing J. Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study). Gynecol Oncol 1984 19: 8 16.
26. Garipagaoglu M, Tulunay G, Kose MF, Yalvac S, Kayikcioglu F, Cakmak A. Prognostic factors in stage IB-IIA cervical carcinomas treated with postoperative radiotherapy. Eur J Gynaecol Oncol 1999 20: 131 5.
27. Plentl AA, Friedman EA. Lymphatic system of the female genitalia. The morphologic basis of oncologic diagnosis and therapy. Major Probl Obstet Gynecol 1971 2: 1 223.
28. Komaki R, Brickner TJ, Hanlon AL, Owen JB, Hanks GE. Long-term results of treatment of cervical carcinoma in the United States in 1973, 1978, and 1983: Patterns of Care Study (PCS). Int J Radiat Oncol Biol Phys 1995 31: 973 82.
29. Kim RY. Radiotherapeutic management in carcinoma of the uterine cervix: current status. Int J Gynecol Cancer 1993 3: 337 48.
30. Barillot I, Horiot JC, Pigneux J et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study: update and multivariate analysis of prognostics factors. Int J Radiat Oncol Biol Phys 1997 38: 969 78.
31. Mendenhall WM, Thar TL, Bova FJ, Marcus RB Jr., Morgan LS, Million RR. Prognostic and treatment factors affecting pelvic control of Stage IB and IIA-B carcinoma of the intact uterine cervix treated with radiation therapy alone. Cancer 1984 53: 2649 54.
32. Hawnaur JM, Johnson RJ, Buckley CH, Tindall V, Isherwood I. Staging, volume estimation and assessment of nodal status in carcinoma of the cervix: comparison of magnetic resonance imaging with surgical findings. Clin Radiol 1994 49: 443 52.
33. Mayr NA, Yuh WT, Zheng J et al. Tumor size evaluated by pelvic examination compared with 3-D quantitative analysis in the prediction of outcome for cervical cancer. Int J Radiat Oncol Biol Phys 1997 39: 395 404.
34. Toita T, Kakinohana Y, Shinzato S et al. Tumor diameter/volume and pelvic node status assessed by magnetic resonance imaging (MRI) for uterine cervical cancer treated with irradiation. Int J Radiat Oncol Biol Phys 1999 43: 777 82.
35. Eifel PJ, Burke TW, Delclos L, Wharton JT, Oswald MJ. Early stage I adenocarcinoma of the uterine cervix: treatment results in patients with tumors less than or equal to 4 cm in diameter. Gynecol Oncol 1991 41: 199 205.
36. Matthews CM, Burke TW, Tornos C et al. Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients. Gynecol Oncol 1993 49: 19 23.
37. Kjorstad KE, Kolbenstvedt A, Strickert T. The value of complete lymphadenectomy in radical treatment of cancer of the cervix, Stage IB. Cancer 1984 54: 2215 9.
38. Grigsby PW, Perez CA, Kuske RR et al. Adenocarcinoma of the uterine cervix: lack of evidence for a poor prognosis. Radiother Oncol 1988 12: 289 96.
39. Kilgore LC, Soong SJ, Gore H, Shingleton HM, Hatch KD, Partridge EE. Analysis of prognostic features in adenocarcinoma of the cervix. Gynecol Oncol 1988 31: 137 53.
40. Waldenstrom AC, Horvath G. Survival of patients with adenocarcinoma of the uterine cervix in western Sweden. Int J Gynecol Cancer 1999 9: 18 23.
41. Baalbergen A, Ewing-Graham PC, Hop WC, Struijk P, Helmerhorst TJ. Prognostic factors in adenocarcinoma of the uterine cervix. Gynecol Oncol 2004 92: 262 7.
42. Sahraoui S, Bouras N, Acharki A et al. Adenocarcinoma of the cervix uteri: a retrospective study of 83 cases. Gynecol Obstet Fertil 2002 30: 291 8.
43. Lanciano RM, Pajak TF, Martz K, Hanks GE. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study. Int J Radiat Oncol Biol Phys 1993 25: 391 7.
44. Perez CA, Grigsby PW, Castro-Vita H, Lockett MA. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1995 32: 1275 88.
45. Kapp KS, Stuecklschweiger GF, Kapp DS et al. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 1998 42: 531 40.
46. Wang CJ, Leung SW, Chen HC et al. High-dose-rate intracavitary brachytherapy (HDR-IC) in treatment of cervical carcinoma: 5-year results and implication of increased low-grade rectal complication on initiation of an HDR-IC fractionation scheme. Int J Radiat Oncol Biol Phys 1997 38: 391 8.
47. Logsdon MD, Eifel PJ. FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 1999 43: 763 75.
48. Eifel PJ, Levenback C, Wharton JT, Oswald MJ. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1995 32: 1289 300.
49. Berman ML, Lagasse LD, Watring WG et al. The operative evaluation of patients with cervical carcinoma by an extraperitoneal approach. Obstet Gynecol 1977 50: 658 64.
50. Twiggs LB, Potish RA, George RJ, Adcock LL. Pretreatment extraperitoneal surgical staging in primary carcinoma of the cervix uteri. Surg Gynecol Obstet 1984 158: 243 50.
51. Hasenburg A, Salama JK, Van TJ, Amosson C, Chiu JK, Kieback DG. Evaluation of patients after extraperitoneal lymph node dissection and subsequent radiotherapy for cervical cancer. Gynecol Oncol 2002 84: 321 6.
52. Childers JM, Hatch KD, Tran AN, Surwit EA. Laparoscopic para-aortic lymphadenectomy in gynecologic malignancies. Obstet Gynecol 1993 82: 741 7.
53. Querleu D, Leblanc E, Castelain B. Laparoscopic pelvic lymphadenectomy in the staging of early carcinoma of the cervix. Am J Obstet Gynecol 1991 164: 579 81.